National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them clinically. Successful early-stage trials of new drugs from this NOFO would transition seamlessly to later stage trials using well-established NCI clinical trial mechanisms.
ROSES 2025: A.17 Hydrosphere is a program element under NASA's Research Opportunities in Space and Earth Sciences omnibus solicitation. It solicits basic and applied supporting research and technology in Earth Science. Proposals are…
Award
Not Announced
About 5 months leftcloses Jan 28, 2027
For program purposes and requirements see the original NOFO under which OVW made the prior award and OVW's FY 2026 Application Companion Guide.
Award
$399.1K
ClosedAug 31, 2026
The U.S.-Africa Strategic Investment Program advances America's national interests by harnessing market-based, private sector-led growth across two strategic focus areas: Critical Minerals Investment and Commercial Diplomacy Acceleration.…
Award
$5.0M – $50.0M
About 9 months leftcloses May 31, 2027
Checked against the notice by the reviewer.
Award
Not Announced
No closing date published